FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FRE - DE0005785604 - Common Stock
47.63 EUR
-0.28 (-0.58%)
We assign a fundamental rating of 4 out of 10 to FRE. FRE was compared to 29 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FRE get a neutral evaluation. Nothing too spectacular is happening here. FRE has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
FRE had positive earnings in the past year.
FRE had a positive operating cash flow in the past year.
FRE had positive earnings in 4 of the past 5 years.
In the past 5 years FRE always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.69%, FRE is in line with its industry, outperforming 55.17% of the companies in the same industry.
With a Return On Equity value of 6.14%, FRE perfoms like the industry average, outperforming 41.38% of the companies in the same industry.
FRE's Return On Invested Capital of 3.26% is on the low side compared to the rest of the industry. FRE is outperformed by 68.97% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FRE is below the industry average of 6.67%.
The last Return On Invested Capital (3.26%) for FRE is above the 3 year average (1.83%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 6.14% | ||
| ROIC | 3.26% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
1.3 Margins
FRE's Profit Margin of 5.11% is amongst the best of the industry. FRE outperforms 93.10% of its industry peers.
In the last couple of years the Profit Margin of FRE has declined.
FRE has a Operating Margin of 9.76%. This is amongst the best in the industry. FRE outperforms 89.66% of its industry peers.
FRE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 24.99%, FRE is in line with its industry, outperforming 51.72% of the companies in the same industry.
FRE's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.76% | ||
| PM (TTM) | 5.11% | ||
| GM | 24.99% |
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
The number of shares outstanding for FRE remains at a similar level compared to 1 year ago.
The number of shares outstanding for FRE has been increased compared to 5 years ago.
FRE has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.06 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.06, FRE is in line with its industry, outperforming 55.17% of the companies in the same industry.
FRE has a debt to FCF ratio of 11.28. This is a negative value and a sign of low solvency as FRE would need 11.28 years to pay back of all of its debts.
FRE's Debt to FCF ratio of 11.28 is on the low side compared to the rest of the industry. FRE is outperformed by 62.07% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
FRE has a Debt to Equity ratio of 0.61. This is amongst the best in the industry. FRE outperforms 82.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 11.28 | ||
| Altman-Z | 2.06 |
ROIC/WACC0.63
WACC5.21%
2.3 Liquidity
FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
FRE has a Current ratio of 1.26. This is in the better half of the industry: FRE outperforms 65.52% of its industry peers.
A Quick Ratio of 0.99 indicates that FRE may have some problems paying its short term obligations.
FRE has a Quick ratio of 0.99. This is in the better half of the industry: FRE outperforms 62.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 215.74% over the past year.
Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 2.13% in the last year.
Measured over the past years, FRE shows a decrease in Revenue. The Revenue has been decreasing by -9.22% on average per year.
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
3.2 Future
Based on estimates for the next years, FRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.63% on average per year.
FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.90% yearly.
EPS Next Y13.2%
EPS Next 2Y12.64%
EPS Next 3Y11.7%
EPS Next 5Y10.63%
Revenue Next Year4.46%
Revenue Next 2Y4.83%
Revenue Next 3Y4.85%
Revenue Next 5Y4.9%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
FRE is valuated correctly with a Price/Earnings ratio of 13.97.
Based on the Price/Earnings ratio, FRE is valued a bit cheaper than 79.31% of the companies in the same industry.
FRE is valuated rather cheaply when we compare the Price/Earnings ratio to 26.76, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 12.47, the valuation of FRE can be described as correct.
68.97% of the companies in the same industry are more expensive than FRE, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of FRE to the average of the S&P500 Index (23.96), we can say FRE is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.97 | ||
| Fwd PE | 12.47 |
4.2 Price Multiples
FRE's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, FRE is valued a bit more expensive than 75.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.37 | ||
| EV/EBITDA | 10.38 |
4.3 Compensation for Growth
FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.06
PEG (5Y)N/A
EPS Next 2Y12.64%
EPS Next 3Y11.7%
5. Dividend
5.1 Amount
FRE has a Yearly Dividend Yield of 2.09%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.40, FRE pays a bit more dividend than its industry peers.
FRE's Dividend Yield is comparable with the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.09% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
59.84% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.64%
EPS Next 3Y11.7%
FRA:FRE (12/12/2025, 9:38:15 AM)
47.63
-0.28 (-0.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners46.81%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.83B
Revenue(TTM)22.35B
Net Income(TTM)1.14B
Analysts86.09
Price Target55.24 (15.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.09% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)5.66%
PT rev (3m)9.61%
EPS NQ rev (1m)-13.24%
EPS NQ rev (3m)-11.29%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)2.8%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.97 | ||
| Fwd PE | 12.47 | ||
| P/S | 1.2 | ||
| P/FCF | 22.37 | ||
| P/OCF | 12.32 | ||
| P/B | 1.44 | ||
| P/tB | 14.49 | ||
| EV/EBITDA | 10.38 |
EPS(TTM)3.41
EY7.16%
EPS(NY)3.82
Fwd EY8.02%
FCF(TTM)2.13
FCFY4.47%
OCF(TTM)3.87
OCFY8.11%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)1.06
PEG (5Y)N/A
Graham Number50.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 6.14% | ||
| ROCE | 6.63% | ||
| ROIC | 3.26% | ||
| ROICexc | 3.7% | ||
| ROICexgc | 8.63% | ||
| OM | 9.76% | ||
| PM (TTM) | 5.11% | ||
| GM | 24.99% | ||
| FCFM | 5.37% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 11.28 | ||
| Debt/EBITDA | 3.4 | ||
| Cap/Depr | 86.4% | ||
| Cap/Sales | 4.38% | ||
| Interest Coverage | 6.84 | ||
| Cash Conversion | 65.69% | ||
| Profit Quality | 104.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 2.06 |
F-Score7
WACC5.21%
ROIC/WACC0.63
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
EPS Next Y13.2%
EPS Next 2Y12.64%
EPS Next 3Y11.7%
EPS Next 5Y10.63%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.46%
Revenue Next 2Y4.83%
Revenue Next 3Y4.85%
Revenue Next 5Y4.9%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year66%
EBIT Next 3Y24.43%
EBIT Next 5Y15.57%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%
FRESENIUS SE & CO KGAA / FRE.DE FAQ
What is the ChartMill fundamental rating of FRESENIUS SE & CO KGAA (FRE.DE) stock?
ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.
What is the valuation status of FRESENIUS SE & CO KGAA (FRE.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for FRESENIUS SE & CO KGAA?
FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.
Can you provide the financial health for FRE stock?
The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 4 / 10.
Can you provide the dividend sustainability for FRE stock?
The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 59.84%.